Drug : Healthy elderly individuals who are eligible to use of statin for primary prevention will be enrolled. They are randomly assigned to moderate intensity statin group and low intensity statin gro
Sponsors
Yonsei University Health System, Severance Hospital
Phase 4
Low- and moderate-intensity Statin and Clinical Outcome of Primary prevention in individuals aged >75 years: the SCOPE-75 RCT Study
Active, not recruitingKCT0003629
Start: 2019-04-16Target: 2484Updated: 2020-02-24
Low- and moderate-intensity Statin and Clinical Outcome of Primary prevention in individuals aged >70 years: the SCOPE-70 RCT Study
RecruitingKCT0004711
Start: 2020-04-17Target: 2484Updated: 2022-10-24